During 2020, Central America's imports of pharmaceutical products containing insulin totaled $35 million, and purchases from Danish companies increased 11% over what was reported in 2019.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with graphic"]
During 2020, companies in the region allocated $134 million for the import of vaccines for human use, and purchases from Russian companies increased 54% over what was reported in 2019.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graph"]
From January to September 2020, companies in the region invested $101 million for the purchase abroad of vaccines for human use, and purchases from Russian companies increased 34% compared to the same period in 2019.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graph"]
From January to September 2020, Central American imports of pharmaceutical products totaled $2.625 billion, an amount that exceeds by just 0.4% what was reported in the same period of 2019.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graph"]
Agencia Farmaceutica S.A., Corporacion Impa Doel S.A., Hispomedica SRL and Cefa Central Farmaceutica are among the companies that won contracts last year to supply medicines and pharmaceutical products to public health institutions in the region.
An analysis by CentralAmericaData's Business Intelligence department provides interesting data on the companies that in 2020 were awarded contracts to supply pharmaceutical products and medical supplies to the different Ministries of Health and Social Security entities in Central American countries and the Dominican Republic.
Nicaragua, Costa Rica and Guatemala are the Central American markets that during the first half of 2020 and in year-on-year terms, increased their imports of pharmaceutical products.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with graphic"]
From January to July 2020, purchases of pharmaceutical products made by Central American countries from Mexican companies totaled $174 million, 7% more than what was reported for the same period in 2019.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with graphic"]
Productos Roche, Drogueria e Importadora Alemana and Corporacion Industrial Farmaceutica are some of the companies that during the first six months of the year won contracts to provide medicines and pharmaceutical products to public health institutions in the region.
The "Interactive Public Procurement Information System" of CentralAmericaData's Trade Intelligence Unit provides interesting data on the companies that in the first half of 2020 were favored with contracts to provide pharmaceutical products and medical supplies to the various Ministries of Health and Social Security entities in the Central American countries.
From January to March 2020, purchases of pharmaceutical products made by Central American countries from companies in Mexico totaled $73 million, 2% more than reported in the same period in 2019.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with graphic"]
From January to September 2019, pharmaceutical product imports in Central America totaled $2.614 million, 8% more than in the same period in 2018, with El Salvador, Panama and Costa Rica being the markets where purchases increased the most.
Figures from the Trade Intelligence Unit at CentralAmericaData: [GRAFICA caption "Click to interact with graphics"]
Elvatron, Seven Pharma, J.I. Cohen, Aceti-Oxigen and Baxter are some of the companies that won contracts to provide medicines and pharmaceutical products to public health institutions in the region last year.
An analysis by the Trade Intelligence Unit of CentralAmericaData provides interesting data on the companies that were favored with contracts to provide pharmaceutical products and medical supplies to the several Ministries of Health and Social Security entities in Central American countries in 2019.
In the first quarter of 2019, purchases of vaccines for human use in Central America totaled $66 million, 347% more than was reported in the same period in 2018.
Figures from the Trade Intelligence Unit at CentralAmericaData: [GRAPHIC caption="Click to interact with graphic"]
Because the country produces only 6% of the medicines demanded, there are several business opportunities that can be explored by industry businessmen.
Currently, local manufacturers do not have the capacity to produce and supply the Panamanian market, which has generated several business opportunities for several companies.
In the first half of 2019, purchases of pharmaceutical products made by Central American countries to companies in Mexico totaled $140 million, 7% less than in the same period of 2018.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with graphic"]